FH:CC News and Press, FILAMENT HEALTH CORP. From 02/15/24

FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL Canada NewsWire Hadassah University Hospital will study PEX010, Filament's botanical psilocybin drug candidate, for the treatment of post-traumatic stress disorder and obsessive-compulsive disorder ...

FILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS Canada NewsWire The active IND allows initiation of US research with Filament's botanical psilocybin drug candidate for the potential treatment of substance use disorders ...

FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA Canada NewsWire Reset Mind Sciences Ltd. has received a shipment of PEX010, Filament's botanical psilocybin drug candidate VANCOUVER, BC , Jan. 17, 2024 /CNW/ - Filament Healt...

FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS Canada NewsWire VANCOUVER, BC , Jan. 2, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development comp...

FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION Canada NewsWire VANCOUVER, BC , Dec. 19, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Compan...

FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE Canada NewsWire VANCOUVER, BC , Dec. 18, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or t...

FILAMENT HEALTH ANNOUNCES ADJOURNMENT OF SPECIAL MEETING Canada NewsWire VANCOUVER, BC , Dec. 11, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural psychedel...

FILAMENT HEALTH FILES AMENDED PRO FORMA FINANCIAL STATEMENTS Canada NewsWire VANCOUVER, BC , Dec. 7, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural ps...

Canadian Investment Regulatory Organization Trade Resumption - FH Canada NewsWire TORONTO , Dec. 6, 2023 /CNW/ - Trading resumes in: Company: FILAMENT HEALTH CORP. NEO Exchange Symbol: FH All Issues: Yes Resumption (ET): 11:00 AM CIRO can make...

FILAMENT HEALTH ANNOUNCES SIGNING OF DEFINITIVE AGREEMENT FOR CONVERTIBLE NOTE FINANCING, CLOSING OF C$900,000 NON-BROKERED PRIVATE PLACEMENT FINANCING, FOUNDER-LED NOTE OFFERING AND OTHER UPDATES RELATED TO UPCOMING SPECIAL MEETING AND PROPOSED BUSINESS COMBINATION Canada NewsWire ...